The invention discloses
streptococcus agalactiae and application of the
streptococcus agalactiae in preparation of drugs for treating
drug-resistant
streptococcus agalactiae infection, the
streptococcus agalactiae is
streptococcus agalactiae S.aXJM001, the
streptococcus agalactiae S.aXJM001 is preserved in the China General
Microbiological Culture Collection Center, the preservation date is January 17, 2025, and the biological preservation number is CGMCC NO.33461. The invention further discloses a preparation method of the streptococcus agalactiae. According to the invention, a
homologous recombination technology is adopted to construct a CovS and CovR double-
gene knockout
mutant strain, a
histidine kinase inhibitor is combined to block a
signal channel, qRT-PCR (quantitative reverse transcription-
polymerase chain reaction) is adopted to measure
signal molecules and
virulence and abundance change of
drug-
resistant genes, and the influence of CovS and CovR genes on the
virulence and
drug resistance of streptococcus agalactiae is explored; the molecular regulation mechanism of the CovS / CovR
system mediated streptococcus agalactiae
virulence and
drug resistance is clarified, and theoretical and technical bases are provided for analysis and research of streptococcus agalactiae
drug treatment targets, so that generation of
drug resistance is reduced, and the CovS / CovR
system mediated streptococcus agalactiae virulence and
drug resistance molecular regulation method has important significance for guaranteeing
quality safety of milk and dairy products.